EUVIMEDEUVIMED entdecken
Crossref

Electrical Sympathetic Neuromodulation Protects Bone Marrow Niche and Drives Hematopoietic Regeneration during Chemotherapy

Ya-Ting Hsu iD, Li-Hsien Chen, Ya-Hui Liu, Shih-Kai Chu, Tsai-Yun Chen, Kuen-Jer Tsai, Meng-Ru Shen iD, Wentai Liu iD

Small Methods · 2023

DOI: 10.1002/smtd.202201300 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small Methods, 2023. Verfasst von Ya-Ting Hsu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, 701401, Taiwan. Hauptthemen laut MEDLINE: Bone Marrow, Hematopoietic Stem Cells. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 70 Literaturangaben. Gefördert von: Ministry of Health and Welfare, Yushan Fellow Program, Ministry of Education and National Cheng Kung University, Taiwan, Ministry of Science and Technology, Taiwan.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The sympathetic nervous system (SNS) of the bone marrow regulates the regeneration and mobilization of hematopoietic stem cells. Chemotherapy can damage bone marrow SNS, which impairs hematopoietic regeneration and aggravates hematologic toxicities. This leads to long‐term bone marrow niche damage and increases mortality in patients undergoing chemotherapy. Electrical neuromodulation has been used to improve functional recovery after peripheral nerve injury. This study demonstrates that electrical sympathetic neuromodulation (ESN) of bone marrow can protect the bone marrow niche from chemotherapy‐induced injury. Using carboplatin‐treated rats, the SNS via the sciatic nerve innervating the femoral marrow with the effective protocol for bone marrow sympathetic activation is electrically stimulated. ESN can mediate several hematopoietic stem cells maintenance factors and promote hematopoietic regeneration after chemotherapy. It also activates adrenergic signals and reduces the release of pro‐inflammatory cytokines, particularly interleukin‐1 β , which contribute to chemotherapy‐related nerve injury. Consequently, the severity of chemotherapy‐related leukopenia, thrombocytopenia, and mortality can be reduced by ESN. As a result, in contrast to current drug‐based treatment, such as granulocyte colony‐stimulating factor, ESN can be a disruptive adjuvant treatment by protecting and modulating bone marrow function to reduce hematologic toxicity during chemotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bone MarrowHematopoietic Stem CellsRatsAnimalsCytokinesBone Marrow CellsGranulocyte Colony-Stimulating Factor

Stichwörter der Autor:innen

bone marrow nichechemotherapy-induced nerve damageelectrical neuromodulationhematopoiesis

Substanzen

CytokinesGranulocyte Colony-Stimulating Factor

Autor:innen und Institutionen

  • Institute of Clinical Medicine, College of Medicine, National Cheng Kung University, Tainan, 701401, Taiwan.
  • Division of Hematology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 704302, Taiwan.
  • Department of Pharmacology, College of Medicine, National Cheng Kung University, Tainan, 701401, Taiwan.
  • Department of Pathology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, 704302, Taiwan.
  • Clinical Medicine Research Center, National Cheng Kung University Hospital, Tainan, 704302, Taiwan.
  • Center of Clinical Medicine, National Cheng Kung University Hospital, College of Medicine National Cheng Kung University, Tainan, 704302, Taiwan.

ORCID-Profile: Ya-Ting Hsu, Meng-Ru Shen, Wentai Liu

Förderung

  • Ministry of Health and Welfare
  • Yushan Fellow Program, Ministry of Education and National Cheng Kung University, Taiwan
  • Ministry of Science and Technology, Taiwan
  • National Cheng Kung University Hospital
  • UCLA Distinguished Professorship

Zitieren

APA

Hsu, Y. T., Chen, L. H., Liu, Y. H., Chu, S. K., Chen, T. Y., Tsai, K. J., Shen, M. R., & Liu, W. (2023). Electrical Sympathetic Neuromodulation Protects Bone Marrow Niche and Drives Hematopoietic Regeneration during Chemotherapy. Small Methods. https://doi.org/10.1002/smtd.202201300

Vancouver

Hsu YT, Chen LH, Liu YH, Chu SK, Chen TY, Tsai KJ, et al. Electrical Sympathetic Neuromodulation Protects Bone Marrow Niche and Drives Hematopoietic Regeneration during Chemotherapy. Small Methods. 2023. doi:10.1002/smtd.202201300

BibTeX
@article{Hsu2023,
  author = {Hsu, Ya-Ting and Chen, Li-Hsien and Liu, Ya-Hui and Chu, Shih-Kai and Chen, Tsai-Yun and Tsai, Kuen-Jer and Shen, Meng-Ru and Liu, Wentai},
  title = {Electrical Sympathetic Neuromodulation Protects Bone Marrow Niche and Drives Hematopoietic Regeneration during Chemotherapy},
  journal = {Small Methods},
  year = {2023},
  doi = {10.1002/smtd.202201300}
}
Kostenlos starten →